Arwa Kurabi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arwa Kurabi has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Allen F. Ryan
Department of Otolaryngology, Head & Neck Surgery, University of California, San Diego
10 shared publicationsKwang Pak
Department of Surgery/Otolaryngology, School of Medicine, University of California San Diego, La Jolla, CA, United States
10 shared publications- Allen Frederic Ryan
University of California San Diego
7 shared publications Anke Leichtle
Univ Lubeck, Dept Otorhinolaryngol, Lubeck, Germany
4 shared publicationsDaniel Schaerer
Department of Surgery/Otolaryngology, UCSD School of Medicine, San Diego, CA, United States
4 shared publicationsEmily Sereno
Department of Otolaryngology, Head & Neck Surgery, University of California, San Diego
3 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by MDPI AG in Preprints.org
Cybernetic, Allostatic, or Both? A Content Analysis of the Redox Code’s Control Architecture
Oxidative stress has traditionally been modeled as linear damage accumulation that antioxidants should reverse, a framing repeatedly contradicted by clinical trials. Jones’s Redox Code reframes redox state as an organized signaling system of non-equilibrium couples (NADH/NAD⁺, NADPH/NADP⁺, GSH/GSSG) and thiol switches, but does not specify its control architecture in systems-theoretic terms. We tested whether Jones’s 2024 review is better described as homeostatic (cybernetic), allostatic, or integrated — a meta-scientific question about conceptualization rather than biology. Fourteen propositions were scored against 25 pre-specified criteria across three models: allostatic (Model A, 9 criteria), cybernetic (Model B, 9 criteria), and integrated (Model C, 7 criteria). Three parallel Claude Sonnet sessions scored all 350 cells; three human raters scored a random 50-cell subset, reported as inter-rater data only. Large Language Model (LLM) reproducibility was high (Krippendorff’s α = 0.873, interval; 0.814, ordinal); human three-rater α was 0.484. LLM aggregate scores favored B (0.175 [95% CI 0.124, 0.219]) over A (0.064) and C (0.062), with a B − A gap of 0.111 [0.052, 0.164] and allostatic signal concentrated in two propositions. Applied to a standard allostatic text (McEwen and Wingfield, 2003), the same rubric returned an allostatic-dominant result (A 0.179, B 0.040). The text of Jones’s 2024 review on the redox organization of living systems is more cybernetic than allostatic, although most cells contained no control-architecture language. LLM scores were not validated against human judgment, and findings are limited to one review. The localized allostatic signal motivates a speculative three-stage control model for future testing.
- 19 November 2026
- Published by MDPI AG in Preprints.org
Open AccessCybernetic, Allostatic, or Both? A Content Analysis of the Redox Code’s Control Architecture
Oxidative stress has traditionally been modeled as linear damage accumulation that antioxidants should reverse, a framing repeatedly contradicted by clinical trials. Jones’s Redox Code reframes redox state as an organized signaling system of non-equilibrium couples (NADH/NAD⁺, NADPH/NADP⁺, GSH/GSSG) and thiol switches, but does not specify its control architecture in systems-theoretic terms. We tested whether Jones’s 2024 review is better described as homeostatic (cybernetic), allostatic, or integrated — a meta-scientific question about conceptualization rather than biology. Fourteen propositions were scored against 25 pre-specified criteria across three models: allostatic (Model A, 9 criteria), cybernetic (Model B, 9 criteria), and integrated (Model C, 7 criteria). Three parallel Claude Sonnet sessions scored all 350 cells; three human raters scored a random 50-cell subset, reported as inter-rater data only. Large Language Model (LLM) reproducibility was high (Krippendorff’s α = 0.873, interval; 0.814, ordinal); human three-rater α was 0.484. LLM aggregate scores favored B (0.175 [95% CI 0.124, 0.219]) over A (0.064) and C (0.062), with a B − A gap of 0.111 [0.052, 0.164] and allostatic signal concentrated in two propositions. Applied to a standard allostatic text (McEwen and Wingfield, 2003), the same rubric returned an allostatic-dominant result (A 0.179, B 0.040). The text of Jones’s 2024 review on the redox organization of living systems is more cybernetic than allostatic, although most cells contained no control-architecture language. LLM scores were not validated against human judgment, and findings are limited to one review. The localized allostatic signal motivates a speculative three-stage control model for future testing.
- Open Access
- 24 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8527
Endocytosis and Endocytic Neurotrophin Signaling in Developing Spiral Ganglion Neurons
Spiral ganglion neurons (SGNs) relay auditory information from cochlear sensory cells to the central nervous system (CNS). During development, neurotrophins (NTs) secreted by sensory and supporting cells promote SGN dendrite outgrowth. In injury models, exogenous NTs have been used to stimulate SGN regeneration after damage. Following ligand binding, NT-Trk receptor complexes are internalized and may undergo recycling or degradation, or remain intracellular as “signaling endosomes” that can be retrogradely transported to the soma to influence gene expression, survival, and neuritogenesis. Here, we investigated the role of Trk-containing endosomes in SGNs. Neonatal rat SG explants were treated with BDNF and NT-3 in combination with inhibitors targeting distinct steps of endocytosis. Neurite number and length were quantified and compared to untreated controls. Inhibition of actin polymerization (cytochalasin-B) or dynamin (Dynasore) strongly suppressed neurite outgrowth in both NT-treated and untreated explants. Similarly, inhibitors of clathrin-mediated endocytosis, including those acting upstream of dynamin, reduced neuritogenesis under both conditions. In contrast, inhibition of clathrin-independent pathways diminished neurite growth only in the absence of NTs. Blocking retrograde transport of endosomes to the trans-Golgi network (Retro-2) selectively increased neurite length in NT-treated explants, while inhibition of retrograde transport along neurites (Mycalolide B) markedly reduced both neurite number and extension regardless of NT treatment. These findings suggest that basal SGN neuritogenesis relies on both clathrin-dependent and clathrin-independent endocytosis, whereas NT-induced neurite growth is specifically mediated through clathrin- and dynamin-dependent mechanisms. Although some inhibitors also disrupt actin polymerization, the lack of effect from clathrin-independent inhibitors supports clathrin-mediated internalization as the predominant pathway for NT-driven SGN growth.
- 24 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8527
Open AccessEndocytosis and Endocytic Neurotrophin Signaling in Developing Spiral Ganglion Neurons
Spiral ganglion neurons (SGNs) relay auditory information from cochlear sensory cells to the central nervous system (CNS). During development, neurotrophins (NTs) secreted by sensory and supporting cells promote SGN dendrite outgrowth. In injury models, exogenous NTs have been used to stimulate SGN regeneration after damage. Following ligand binding, NT-Trk receptor complexes are internalized and may undergo recycling or degradation, or remain intracellular as “signaling endosomes” that can be retrogradely transported to the soma to influence gene expression, survival, and neuritogenesis. Here, we investigated the role of Trk-containing endosomes in SGNs. Neonatal rat SG explants were treated with BDNF and NT-3 in combination with inhibitors targeting distinct steps of endocytosis. Neurite number and length were quantified and compared to untreated controls. Inhibition of actin polymerization (cytochalasin-B) or dynamin (Dynasore) strongly suppressed neurite outgrowth in both NT-treated and untreated explants. Similarly, inhibitors of clathrin-mediated endocytosis, including those acting upstream of dynamin, reduced neuritogenesis under both conditions. In contrast, inhibition of clathrin-independent pathways diminished neurite growth only in the absence of NTs. Blocking retrograde transport of endosomes to the trans-Golgi network (Retro-2) selectively increased neurite length in NT-treated explants, while inhibition of retrograde transport along neurites (Mycalolide B) markedly reduced both neurite number and extension regardless of NT treatment. These findings suggest that basal SGN neuritogenesis relies on both clathrin-dependent and clathrin-independent endocytosis, whereas NT-induced neurite growth is specifically mediated through clathrin- and dynamin-dependent mechanisms. Although some inhibitors also disrupt actin polymerization, the lack of effect from clathrin-independent inhibitors supports clathrin-mediated internalization as the predominant pathway for NT-driven SGN growth.
- Open Access
Comparative Antioxidant Protection of Cochlear Hair Cells from Ototoxins
Many forms of damage to cochlear sensory cells involve reactive oxygen species (ROS). We previously screened 81 antioxidants in vitro for the ability to reduce cochlear hair cell (HC) damage by the ototoxic aminoglycoside gentamicin. Only 13 antioxidants produced significant reduction in HC loss, with the quinone antioxidants seratrodast and idebenone being most protective. Why so few antioxidants were protective is unclear, but most antioxidants have other properties that could enhance or detract from protection. In particular, seratrodast is a potent thromboxane A2 (TXA2) antagonist, while idebenone also strongly supports cell metabolism by enhancing mitochondrial function. We therefore asked whether a different TXA2 inhibitor (SQ-29548) or mitochondrial function enhancer (mitochonic acid) exhibited any HC protective ability in the same assay. In both cases, no significant protection from gentamicin was observed, indicating that the ROS scavenging activity of seratrodast and idebenone accounted for HC protection. Additionally, to assess the generality of HC protection by the two antioxidants, we assessed their potential for protection against cisplatin, an ototoxic anti-cancer drug that produces HC damage through a different mechanism than aminoglycosides, but which also involves ROS. High-dose seratrodast tested protected HCs from cisplatin damage, but not to the extent observed for gentamicin. High-dose idebenone was also protective, but even less than for seratrodast. Neither mitochonic acid nor SQ-29548 was protective against cisplatin. The results indicate that seratrodast and idebenone provide HC protection from gentamicin and cisplatin due to their free radical scavenging properties, but protection from cisplatin was less effective, presumably due to its different mechanism of ototoxicity.
Open AccessComparative Antioxidant Protection of Cochlear Hair Cells from Ototoxins
Many forms of damage to cochlear sensory cells involve reactive oxygen species (ROS). We previously screened 81 antioxidants in vitro for the ability to reduce cochlear hair cell (HC) damage by the ototoxic aminoglycoside gentamicin. Only 13 antioxidants produced significant reduction in HC loss, with the quinone antioxidants seratrodast and idebenone being most protective. Why so few antioxidants were protective is unclear, but most antioxidants have other properties that could enhance or detract from protection. In particular, seratrodast is a potent thromboxane A2 (TXA2) antagonist, while idebenone also strongly supports cell metabolism by enhancing mitochondrial function. We therefore asked whether a different TXA2 inhibitor (SQ-29548) or mitochondrial function enhancer (mitochonic acid) exhibited any HC protective ability in the same assay. In both cases, no significant protection from gentamicin was observed, indicating that the ROS scavenging activity of seratrodast and idebenone accounted for HC protection. Additionally, to assess the generality of HC protection by the two antioxidants, we assessed their potential for protection against cisplatin, an ototoxic anti-cancer drug that produces HC damage through a different mechanism than aminoglycosides, but which also involves ROS. High-dose seratrodast tested protected HCs from cisplatin damage, but not to the extent observed for gentamicin. High-dose idebenone was also protective, but even less than for seratrodast. Neither mitochonic acid nor SQ-29548 was protective against cisplatin. The results indicate that seratrodast and idebenone provide HC protection from gentamicin and cisplatin due to their free radical scavenging properties, but protection from cisplatin was less effective, presumably due to its different mechanism of ototoxicity.
- Open Access
- 17 February 2025
- Published by Taylor & Francis in Drug Delivery
- Vol. 32 (1) , 2463427
Peptides rapidly transport antibiotic across the intact tympanic membrane to treat a middle ear infection
The tympanic membrane (TM) forms an impenetrable barrier to medical therapies for middle ear (ME) diseases like otitis media. By screening a phage-displayed peptide library, we have previously discovered rare peptides that mediate the active transport of cargo across the intact membrane of animals and humans. Since the M13 filamentous bacteriophage on which the peptides are expressed are large (nearly 1 µm in length), this offers the possibility of noninvasively delivering drugs, large drug packages, or gene therapy to the ME. To evaluate this possibility, EDC chemistry was employed to covalently attach amoxicillin, or neomycin molecules to phage bearing a trans-TM peptide, as a model for large drug packages. Eight hours after application of antibiotic-phage to the TM of infected rats, ME bacterial titers were substantially reduced compared to untreated animals. As a control, antibiotic was linked to wild-type phage, not bearing any peptide, and application to the TM did not affect ME bacteria. The results support the ability of rare peptides to actively deliver pharmacologically relevant amounts of drugs through the intact TM and into the ME. Moreover, since bacteriophage engineered to express peptides are viral vectors, the trans-TM peptides could also transport other viral vectors into the ME.
- 17 February 2025
- Published by Taylor & Francis in Drug Delivery
- Vol. 32 (1) , 2463427
Open AccessPeptides rapidly transport antibiotic across the intact tympanic membrane to treat a middle ear infection
The tympanic membrane (TM) forms an impenetrable barrier to medical therapies for middle ear (ME) diseases like otitis media. By screening a phage-displayed peptide library, we have previously discovered rare peptides that mediate the active transport of cargo across the intact membrane of animals and humans. Since the M13 filamentous bacteriophage on which the peptides are expressed are large (nearly 1 µm in length), this offers the possibility of noninvasively delivering drugs, large drug packages, or gene therapy to the ME. To evaluate this possibility, EDC chemistry was employed to covalently attach amoxicillin, or neomycin molecules to phage bearing a trans-TM peptide, as a model for large drug packages. Eight hours after application of antibiotic-phage to the TM of infected rats, ME bacterial titers were substantially reduced compared to untreated animals. As a control, antibiotic was linked to wild-type phage, not bearing any peptide, and application to the TM did not affect ME bacteria. The results support the ability of rare peptides to actively deliver pharmacologically relevant amounts of drugs through the intact TM and into the ME. Moreover, since bacteriophage engineered to express peptides are viral vectors, the trans-TM peptides could also transport other viral vectors into the ME.
- Open Access
- 19 December 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (12) , 1632
Peptide-Mediated Transport Across the Intact Tympanic Membrane Is Intracellular, with the Rate Determined by the Middle Ear Mucosal Epithelium
The tympanic membrane forms an impenetrable barrier between the ear canal and the air-filled middle ear, protecting it from fluid, pathogens, and foreign material entry. We previously screened a phage display library and discovered peptides that mediate transport across the intact membrane. The route by which transport occurs is not certain, but possibilities include paracellular transport through loosened intercellular junctions and transcellular transport through the cells that comprise the various tympanic membrane layers. We used confocal imaging to resolve the phage’s path through the membrane. Phages were observed in puncta within the cytoplasm of tympanic membrane cells, with no evidence of phages within junctions between epithelial cells. This result indicates that transport across the membrane is transcellular and within vesicles, consistent with the transcytosis process. The trans-tympanic peptide phages display a wide range of transport efficiencies for unknown reasons. This could include variation in tympanic membrane binding, entry into the membrane, crossing the membrane, or exiting into the middle ear. To address this, we titered phages recovered from within the membrane for phages with differing transport rates. We found that differences in the transport rate were inversely related to their presence within the tympanic membrane. This suggests that differences in the transport rate primarily reflect the efficiency of an exocytotic exit from the mucosal epithelium rather than entry into, or passage across, the membrane.
- 19 December 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (12) , 1632
Open AccessPeptide-Mediated Transport Across the Intact Tympanic Membrane Is Intracellular, with the Rate Determined by the Middle Ear Mucosal Epithelium
The tympanic membrane forms an impenetrable barrier between the ear canal and the air-filled middle ear, protecting it from fluid, pathogens, and foreign material entry. We previously screened a phage display library and discovered peptides that mediate transport across the intact membrane. The route by which transport occurs is not certain, but possibilities include paracellular transport through loosened intercellular junctions and transcellular transport through the cells that comprise the various tympanic membrane layers. We used confocal imaging to resolve the phage’s path through the membrane. Phages were observed in puncta within the cytoplasm of tympanic membrane cells, with no evidence of phages within junctions between epithelial cells. This result indicates that transport across the membrane is transcellular and within vesicles, consistent with the transcytosis process. The trans-tympanic peptide phages display a wide range of transport efficiencies for unknown reasons. This could include variation in tympanic membrane binding, entry into the membrane, crossing the membrane, or exiting into the middle ear. To address this, we titered phages recovered from within the membrane for phages with differing transport rates. We found that differences in the transport rate were inversely related to their presence within the tympanic membrane. This suggests that differences in the transport rate primarily reflect the efficiency of an exocytotic exit from the mucosal epithelium rather than entry into, or passage across, the membrane.
- 30 December 2023
- Published by Springer Nature
- p. 169-175
Drug Delivery Across the Intact Tympanic Membrane: Methods, Mechanisms and Potential Impact
- 30 December 2023
- Published by Springer Nature
- p. 169-175
Drug Delivery Across the Intact Tympanic Membrane: Methods, Mechanisms and Potential Impact
- Open Access
- 10 December 2023
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 176, 111814
PANEL 3: Otitis media animal models, cell culture, tissue regeneration & pathophysiology
- 10 December 2023
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 176, 111814
Open AccessPANEL 3: Otitis media animal models, cell culture, tissue regeneration & pathophysiology
- Open Access
- 3 August 2023
- Published by Springer Nature in Research Square
Peptides Rapidly Transport Antibiotic Across the Intact Tympanic Membrane to Treat a Middle Ear Infection
The tympanic membrane (TM) forms an impermeable barrier to medical therapies for middle ear (ME) diseases like otitis media. By screening a phage-displayed peptide library, we have previously discovered rare peptides that mediate active transport of cargo across the intact membrane of animals and humans. Since the M13 filamentous bacteriophage on which the peptides are expressed are large (nearly 1 µm in length), this offers the possibility of noninvasively delivering drugs, large drug packages or gene therapy to the ME. To evaluate this possibility, EDC chemistry was employed to covalently attach amoxicillin or neomycin molecules to phage bearing a trans-TM peptide, as a model for large drug packages. Eight hours after application of antibiotic-phage to the TM of infected rats, ME bacterial titers were substantially reduced compared to untreated animals. As a control, antibiotic was linked to wild-type phage, not bearing any peptide, and application to the TM did not affect ME bacteria. The results support the ability of rare peptides to actively deliver pharmacologically relevant amounts of drugs through the intact TM and into the ME. Moreover, since bacteriophage engineered to express peptides are viral vectors, the trans-TM peptides could also transport other viral vectors into the ME.
- 3 August 2023
- Published by Springer Nature in Research Square
Open AccessPeptides Rapidly Transport Antibiotic Across the Intact Tympanic Membrane to Treat a Middle Ear Infection
The tympanic membrane (TM) forms an impermeable barrier to medical therapies for middle ear (ME) diseases like otitis media. By screening a phage-displayed peptide library, we have previously discovered rare peptides that mediate active transport of cargo across the intact membrane of animals and humans. Since the M13 filamentous bacteriophage on which the peptides are expressed are large (nearly 1 µm in length), this offers the possibility of noninvasively delivering drugs, large drug packages or gene therapy to the ME. To evaluate this possibility, EDC chemistry was employed to covalently attach amoxicillin or neomycin molecules to phage bearing a trans-TM peptide, as a model for large drug packages. Eight hours after application of antibiotic-phage to the TM of infected rats, ME bacterial titers were substantially reduced compared to untreated animals. As a control, antibiotic was linked to wild-type phage, not bearing any peptide, and application to the TM did not affect ME bacteria. The results support the ability of rare peptides to actively deliver pharmacologically relevant amounts of drugs through the intact TM and into the ME. Moreover, since bacteriophage engineered to express peptides are viral vectors, the trans-TM peptides could also transport other viral vectors into the ME.
- Open Access
- 9 November 2022
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 958540
Resolution of otitis media in a humanized mouse model
Otitis media (OM) is one of the largest public health problems of children and has devastating impacts in developing countries. The substantial medical and human costs involved have led to research to understand the disease and improve treatment. Animal models of OM have yielded critical information about the immune, inflammatory and genetic mechanisms of OM. However, it is important to link animal studies to human immune and inflammatory responses. In recent years, “humanized” mice have become a valuable tool to study the human immune system in an animal model. Here we describe the first use of humanized mice to study OM. We demonstrate that humanized mice with a sufficient degree of engraftment recapitulate a normal middle ear (ME) inflammatory response to bacterial infection, including the recruitment of human immune cells, and exhibit normal recovery. Moreover, these animals exhibit regulated expression of human-specific immune and inflammatory genes in the ME. In contrast, mice with insufficient engraftment fail to resolve OM. This model has many potential uses in OM research, including using hematopoietic stem cells from patients with differing degrees of OM susceptibility, to understand the role of human immune responses in proneness to this common childhood disease.
- 9 November 2022
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 958540
Open AccessResolution of otitis media in a humanized mouse model
Otitis media (OM) is one of the largest public health problems of children and has devastating impacts in developing countries. The substantial medical and human costs involved have led to research to understand the disease and improve treatment. Animal models of OM have yielded critical information about the immune, inflammatory and genetic mechanisms of OM. However, it is important to link animal studies to human immune and inflammatory responses. In recent years, “humanized” mice have become a valuable tool to study the human immune system in an animal model. Here we describe the first use of humanized mice to study OM. We demonstrate that humanized mice with a sufficient degree of engraftment recapitulate a normal middle ear (ME) inflammatory response to bacterial infection, including the recruitment of human immune cells, and exhibit normal recovery. Moreover, these animals exhibit regulated expression of human-specific immune and inflammatory genes in the ME. In contrast, mice with insufficient engraftment fail to resolve OM. This model has many potential uses in OM research, including using hematopoietic stem cells from patients with differing degrees of OM susceptibility, to understand the role of human immune responses in proneness to this common childhood disease.
- Open Access
- 26 August 2022
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 932555
The ECRG4 cleavage product augurin binds the endotoxin receptor and influences the innate immune response during otitis media
Otitis media (OM), the most common disease of childhood, is typically characterized by bacterial infection of the middle ear (ME). Prominent features of OM include hyperplasia of the ME mucosa, which transforms from a monolayer of simple squamous epithelium with minimal stroma into a full-thickness respiratory epithelium in 2–3 days after infection. Analysis of the murine ME transcriptome during OM showed down-regulation of the tumor suppressor gene Ecrg4 that was temporally related to mucosal hyperplasia and identified stromal cells as the primary ECRG4 source. The reduction in Ecrg4 gene expression coincided with the cleavage of ECRG4 protein to release an extracellular fragment, augurin. The duration of mucosal hyperplasia during OM was greater in Ecrg4−/− mice, the number of infiltrating macrophages was enhanced, and ME infection cleared more rapidly. ECRG4-null macrophages showed increased bacterial phagocytosis. Co-immunoprecipitation identified an association of augurin with TLR4, CD14 and MD2, the components of the lipopolysaccharide (LPS) receptor. The results suggest that full-length ECRG4 is a sentinel molecule that potentially inhibits growth of the ME stroma. Processing of ECRG4 protein during inflammation, coupled with a decline in Ecrg4 gene expression, also influences the behavior of cells that do not express the gene, limiting the production of growth factors by epithelial and endothelial cells, as well as the activity of macrophages.
- 26 August 2022
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 932555
Open AccessThe ECRG4 cleavage product augurin binds the endotoxin receptor and influences the innate immune response during otitis media
Otitis media (OM), the most common disease of childhood, is typically characterized by bacterial infection of the middle ear (ME). Prominent features of OM include hyperplasia of the ME mucosa, which transforms from a monolayer of simple squamous epithelium with minimal stroma into a full-thickness respiratory epithelium in 2–3 days after infection. Analysis of the murine ME transcriptome during OM showed down-regulation of the tumor suppressor gene Ecrg4 that was temporally related to mucosal hyperplasia and identified stromal cells as the primary ECRG4 source. The reduction in Ecrg4 gene expression coincided with the cleavage of ECRG4 protein to release an extracellular fragment, augurin. The duration of mucosal hyperplasia during OM was greater in Ecrg4−/− mice, the number of infiltrating macrophages was enhanced, and ME infection cleared more rapidly. ECRG4-null macrophages showed increased bacterial phagocytosis. Co-immunoprecipitation identified an association of augurin with TLR4, CD14 and MD2, the components of the lipopolysaccharide (LPS) receptor. The results suggest that full-length ECRG4 is a sentinel molecule that potentially inhibits growth of the ME stroma. Processing of ECRG4 protein during inflammation, coupled with a decline in Ecrg4 gene expression, also influences the behavior of cells that do not express the gene, limiting the production of growth factors by epithelial and endothelial cells, as well as the activity of macrophages.